SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-048441
Filing Date
2014-02-12
Accepted
2014-02-12 17:29:06
Documents
10
Period of Report
2014-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d675285d8k.htm 8-K 32454
2 EX-1.1 d675285dex11.htm EX-1.1 245890
3 EX-4.1 d675285dex41.htm EX-4.1 330834
4 EX-4.2 d675285dex42.htm EX-4.2 323047
5 EX-5.1 d675285dex51.htm EX-5.1 10180
6 EX-99.1 d675285dex991.htm EX-99.1 7790
7 GRAPHIC g675285g45p38.jpg GRAPHIC 25447
8 GRAPHIC g675285g49g69.jpg GRAPHIC 28087
9 GRAPHIC g675285g55q50.jpg GRAPHIC 31430
10 GRAPHIC g675285g68y98.jpg GRAPHIC 23108
  Complete submission text file 0001193125-14-048441.txt   1101136
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 14601599
SIC: 2836 Biological Products, (No Diagnostic Substances)